Long COVID top news

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

AML was the most prevalent hematologic malignancy associated with invasive aspergillosis

Publish date:: July 22, 2020

Key clinical point: Acute myeloid leukemia (31.5%) was documented as the most prevalent risk factor among subjects with IA.

Major finding: The incident rate of invasive aspergillosis was 23.3%.

Study details: Descriptive cross-sectional study of 150 patients with different types of hematologic malignancies.

Disclosures: The authors declared they had no conflicts of interest.

Citation:

Ardi P et al. Microbial Pathogenesis. 2020; doi.org/10.1016/j.micpath.2020.104382.

This Week's Must Reads

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

COVID-19–induced drop in first measles vaccinations sparks resurgence concerns,

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Three genes could predict congenital Zika infection susceptibility,

‘Excellent short-term outcomes’ seen in HCV+ liver transplants to HCV– recipients,

Must Reads in Invasive fungal infections

Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy,

Infection with Fusarium is a risk in hematology patients,

Primary immunodeficiency disease patients have high risk of invasive fungal disease,

MicroRNAs can distinguish invasive aspergillosis in lung transplant recipients,

Saliva-controlled sputum culture aids diagnosis of deep pulmonary infections,